Page 45 - M. Immunology
P. 45

A Novel Peptide from Spider Venom, Lycotoxin-Pa4a, Exhibits Antibacterial
                                 and Anti-inflammatory Activities

                                                                                       1*
                                               1
                                                                        2
                                                           1
                     Min Kyoung Shin , In-Wook Hwang , Yunkyung Kim , Seung-Tae Kim , and Jung-Suk Sung
                                  1

                                           1 Department of Life Science, Dongguk University-Seoul, Goyang 10326, Republic of Korea
                                         2 Life and Environment Research Institute, Konkuk University, Seoul 05029, Republic of Korea
                  BACKGROUND                                                   AIM
   The  emergence  of  drug-resistant  bacteria  has  become  a  global  issue,  increasing  the   In this study, the transcriptome of an indigenous spider in Korea, Pardosa astrigera (P.
   demand for a new source of antibiotics. Antimicrobial peptides (AMPs) are found in a   astrigera), were analyzed for the identification of a novel AMP based on comparative
   wide  range  of  organisms  where  it  may  exhibit  multiple  functionalities  such  as   analysis  of  homology  and  structural  characteristics  with  known  toxin  peptides.  The
   immunomodulatory and anticancer effects along with its primary antibacterial activity.   potential of utilizing toxin peptide and RNA transcripts for drug design was suggested
   AMPs have drawn attention as next-generation antibiotics due  to  its  high selectivity   by  the  investigation  of  antibacterial  activity  and  immunomodulatory  effect.  The
   and lower side effects. The venom of spider is a rich source of bioactive components,   functionality of the toxin component can bring insight into the mode of action of which
   as it is used for both predation and defense.         the venom acts.
                                                METHODS
     Sample preparation – Venom glands of P. astrigera were separated for the extraction of total RNA. Transcriptome library was conducted by subsequent RNA sequencing using
      the NGS technique.
     Antibacterial  activity  assay  –  Colony-forming  unit  assay  was  performed  using  gram-negative  (E.  coli,  P.  aeruginosa)  and  gram-positive  bacteria  (B.  cereus,  ,  S.  aureus)  to
      determine antibacterial activity. Relative colony formation was measured by counting colonies on each plate.
     Membrane  permeability  test  –  Permeabilization  of  bacterial  outer  membrane  and  cytoplasmic  membrane  was  determined  by  using  dyes  NPN  and  DiSC 3 (5),  respectively.
      Fluorescence intensity was measured after treatment of the peptide and compared with that of melittin.
      NO assay & cell viability assay – Murine macrophage RAW 264.7 were treated with several concentrations of the peptide. Each of supernatant and cells were subjected for NO
      measurement and viability test.
     RT-qPCR & western blot analysis – After treatment of the peptide with or without LPS, total RNA or protein was extracted from the cells. Gene expression of inflammatory
      mediators were measured by RT-qPCR, and change in activity of MAPK pathway was detected via immunoblotting.

                                                 RESULTS














    Figure 1. Identification of Lycotoxin-Pa4a.   Figure 2. Lycotoxin-Pa4a exhibited antibacterial activity.   Figure 3. Permeation of bacterial membrane by Lycotoxin-Pa4a.
    Homology  and  in  silico  analysis  of  P.  astrigera  transcriptome  revealed  precursor   Antibacterial  activity  of  Lycotoxin-Pa4a  was  conducted  via  CFU  assay.   Mechanism  underlying  antibacterial  activity  of  Lycotoxin-Pa4a  was  studied
    sequence with 75-mer mature peptide. Structural characteristics of the sequence   Lycotoxin-Pa4a  showed  significant  inhibition  of  growth  against   using fluorescence dye. The peptide disrupted the outer membrane of gram-
    were  predicted  as  cysteine-rich  N-terminal  and  α-helical  C-terminal  region.  The   pathogenic  strains  including  E.  coli,  P.  aeruginosa,  B.  cereus,  and  S.   negative  strains and  depolarized  the  cytoplasmic membrane  of  both  gram-
    sequence was named Lycotoxin-Pa4a and subjected to functional analysis.    aureus.   positive and negative strains.














      Figure 4. Lycotoxin-Pa4a showed anti-inflammatory effect on LPS-stimulated RAW264.7 model.   Figure 5. MAPK pathway was inactivated via Lycotoxin-Pa4a.
      The  treatment  of  the  peptide  decreased  the  NO  production  by  dose-dependent  manner  without  causing   MAPK  pathway  was  investigated  to  explain  anti-inflammatory  activity  of  Lycotoxin-Pa4a  as  the  molecular
      significant cell damage. The gene expression level of pro-inflammatory mediators (iNOS, COX2, TNF-α, IL-1β)   pathway is stimulated by LPS-TLR4 interaction. The phosphorylation of ERK, JNK, and p38 were all inactivated by
      decreased while anti-inflammatory cytokine IL-10 increased upon treatment of Lycotoxin-Pa4a.     the peptide which was similar to the results of mRNA expression.
          CONCLUSION                         REFERENCES                    ACKNOWLEDGEMENTS
   A  novel  peptide  Lycotoxin-Pa4a  was  identified   1. Shin, M.K.; Hwang, I.-W.; Kim, Y.; Kim, S.T.; Jang, W.; Lee, S.; Bang,
   from  the  transcriptome  of  the  venom  gland  of   W.Y.;  Bae,  C.-H.;  Sung,  J.-S.  Antibacterial  and  Anti-Inflammatory   This research was supported by a grant from the
                                       Effects  of  Novel  Peptide  Toxin  from  the  Spider  Pardosa  astrigera.
   the  spider  Pardosa  astrigera.  Lycotoxin-Pa4a   Antibiotics 2020, 9(7), 422.    National Institute of Biological Resources (NIBR)
   showed antibacterial activity against both gram-                        funded by the Ministry of Environment (MOE) of
                                       2.  Kozlov,  S.A.;  Vassilevski,  A.A.;  Feofanov,  A.V.;  Surovoy,  A.Y.;
   negative  and  gram-positive  strains  through  the   Karpunin,  D.Y.;  Grishin,  E.V.  Latarcins,  antimicrobial  and  cytolytic   the Republic of Korea (NIBR202009201) and the
   permeabilization  of  bacterial   membranes.   peptides  from  the  venom  of  the  spider  Lachesana  tarabaevi   Dongguk University Research Fund of 2019.
                                       (Zodariidae) that exemplify biomolecular diversity. J. Biol. Chem. 2006,
   Moreover, the peptide treatment on the murine   281, 20983–20992.
   macrophage model modulated the expression of   3.  Nguyen,  L.T.;  Haney,  E.F.;  Vogel,  H.J.  The  expanding  scope  of
   inflammatory  mediators  by  inactivating  the   antimicrobial  peptide  structures  and  their  modes  of  action.  Trends   CONTACT   INFORMATION
   MAPK  pathway.  Our  study  demonstrated  the   Biotechnol. 2011, 29, 464–472.
   identification of Lycotoxin-Pa4a, an antimicrobial   4. Ko, S.J.; Park, E.; Asandei, A.; Choi, J.-Y.; Lee, S.-C.; Seo, C.H.; Luchian,     Email : samantha1994@naver.com
   peptide  with  anti-inflammatory  activity,  and  its   T.;  Park,  Y.  Bee  venom-derived  antimicrobial  peptide  melectin  has   Tel. : +82-10-2499-3561
                                       broad-spectrum potency, cell selectivity, and salt-resistant properties.   
   potential as a new source for antibiotics.    Sci. Rep. 2020, 10, 10145.
   40   41   42   43   44   45   46   47   48   49   50